Systematic Review of Randomized Controlled Trials of Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension

Effects of oral treatments on clinical outcomes in pulmonary arterial hypertension: A systematic review and meta-analysis

(2015) Hong-Da Zhang et al.   AMERICAN HEART JOURNAL

Comparative Safety and Tolerability of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension

(2015) Meghan Aversa et al.   DRUG SAFETY

Combination Therapy in Pulmonary Arterial Hypertension

(2013) Richard N. Channick   AMERICAN JOURNAL OF CARDIOLOGY

Bosentan Treatment Is Associated With Improvement of Right Ventricular Function and Remodeling in Chronic Thromboembolic Pulmonary Hypertension

(2013) Sulaiman Surie et al.   CLINICAL CARDIOLOGY

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

(2013) Tomás Pulido et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials

(2012) Nicole B. Gabler et al.   CIRCULATION

Pathophysiological Roles of Endothelin Receptors in Cardiovascular Diseases

(2012) Mamoru Ohkita et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension?

(2012) Gianluigi Savarese et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Endothelin receptor antagonists for the treatment of pulmonary artery hypertension

(2012) Lewis J. Rubin   LIFE SCIENCES

A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn

(2011) W A Mohamed et al.   Journal of Perinatology

Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension

(2011) Julio Sandoval et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies

(2010) Robyn J. Barst et al.   BRITISH JOURNAL OF HAEMATOLOGY

Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension

(2010) Zhi-Cheng Jing et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: A subgroup analysis

(2009) Rolf M.F. Berger et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension

(2009) Ronald J. Oudiz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sitaxsentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Raymond L. Benza et al.   CHEST

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Nazzareno Galiè et al.   CIRCULATION

Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension

(2008) Xavier Jaïs et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

(2008) N Galiè et al.   LANCET